Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life time in humans after IV administration.
Constraint: You must select all options from a, b, or c without using any other words.
Options:
a.) CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O
b.) COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
c.) COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC
Answer: b
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone